146 related articles for article (PubMed ID: 4108905)
1. Histamine excretion and dermographism in urticaria pigmentosa before and after administration of a specific histidine-decarboxylase inhibitor.
Greaves MW
Br J Dermatol; 1971 Nov; 85(5):467-70. PubMed ID: 4108905
[No Abstract] [Full Text] [Related]
2. Minimal effect of complete H1 receptor blockade on urticaria pigmentosa.
Krause LB; Shuster S
Acta Derm Venereol; 1985; 65(4):338-40. PubMed ID: 2413691
[TBL] [Abstract][Full Text] [Related]
3. Treatment of two mastocytosis patients with a histidine decarboxylase inhibitor.
Granerus G; Olafsson JH; Roupe G
Agents Actions; 1985 Apr; 16(3-4):244-8. PubMed ID: 4013913
[TBL] [Abstract][Full Text] [Related]
4. Studies on urticaria pigmentosa.
Roychowdhury DS; Banerjee AK
Bull Calcutta Sch Trop Med; 1971 Apr; 19(2):39-40. PubMed ID: 4144296
[No Abstract] [Full Text] [Related]
5. Generalized mastocytosis.
van Kammen E
Acta Haematol; 1974; 52(3):129-40. PubMed ID: 4138774
[No Abstract] [Full Text] [Related]
6. General anesthesia in a child with urticaria pigmentosa.
Coleman MA; Liberthson RR; Crone RK; Levine FH
Anesth Analg; 1980 Sep; 59(9):704-6. PubMed ID: 6106441
[No Abstract] [Full Text] [Related]
7. [Clinical forms of mastocytosis].
Chwalińska-Sadowska H; Polowiec Z
Reumatologia; 1973 Jan; 11(1):91-5. PubMed ID: 4144560
[No Abstract] [Full Text] [Related]
8. The effect of the histidine decarboxylase inhibitor brocresine (NSD-1055) on gastric acid secretion in rats.
Becker M; Sewing KF
J Pharm Pharmacol; 1971 Jun; 23(6):434-7. PubMed ID: 4397183
[No Abstract] [Full Text] [Related]
9. Brocresine, a histidine decarboxylase inhibitor, in chronic urticaria.
Zachariae H; Brodthagen H; Sondergaard J
J Invest Dermatol; 1969 Nov; 53(5):341-3. PubMed ID: 5347413
[No Abstract] [Full Text] [Related]
10. Increased production of prostaglandin D2 in patients with systemic mastocytosis.
Roberts LJ; Sweetman BJ; Lewis RA; Austen KF; Oates JA
N Engl J Med; 1980 Dec; 303(24):1400-4. PubMed ID: 6107852
[No Abstract] [Full Text] [Related]
11. The effect of brocresine (NSD-1055) on the histidine decarboxylase activity in the rat gastric mucosa.
Mesch H; Sewing KF
J Pharm Pharmacol; 1971 Jul; 23(7):506-8. PubMed ID: 4397449
[No Abstract] [Full Text] [Related]
12. [Histidine decarboxylase inhibitors].
Kasztreiner E; Szilágyi G; Szakályné KJ; Huszti Z; Kürti M
Acta Pharm Hung; 1973 Jul; 43(3):121-5. PubMed ID: 4127039
[No Abstract] [Full Text] [Related]
13. Hyperchlorhydria and hyperhistaminemia in a patient with systemic mastocytosis.
Keller RT; Roth HP
N Engl J Med; 1970 Dec; 283(26):1449-50. PubMed ID: 5481779
[No Abstract] [Full Text] [Related]
14. Treatment of adjuvant arthritis in rats with the histidine decarboxylase inhibitor hypostamine.
Pelczarska A
J Pharm Pharmacol; 1969 Oct; 21(10):692-3. PubMed ID: 4390614
[No Abstract] [Full Text] [Related]
15. [Considerations on the histidine-decarboxylase inhibitor (554 L) in the treatment of pruriginous disease].
Abry M
Lyon Med; 1967 Mar; 217(10):753-6. PubMed ID: 4387192
[No Abstract] [Full Text] [Related]
16. Failure of brocresine (NSD 1055)--a histidine decarboxylase inhibitor--to influence skin histamine in mice.
Zachariae H; Sondergaard J; Husseini R; Carlsen R
Acta Allergol; 1970 Jun; 25(2):216-20. PubMed ID: 5536091
[No Abstract] [Full Text] [Related]
17. The use of antihistidine decarboxylase combined with an antihistamine in the treatment of allergic dermatoses.
LUBOWE II
Urol Cutaneous Rev; 1952 Feb; 56(2):98-100. PubMed ID: 14913829
[No Abstract] [Full Text] [Related]
18. Urticaria pigmentosa (mastocytosis).
Khanna N; D'Souza P
Indian Pediatr; 1998 Mar; 35(3):253-4. PubMed ID: 9707879
[No Abstract] [Full Text] [Related]
19. Urticaria pigmentosa. Histaminuria and treatment.
Tabar AI; Vives R; Valcayo A; Montes M; Varela JI
Allergol Immunopathol (Madr); 1990; 18(2):101-3. PubMed ID: 1973586
[TBL] [Abstract][Full Text] [Related]
20. Histamine in DAB induced hepatoma and effect of tritogualin and compound 48-80 on the incidence and development of the tumor.
Bini A; Frontini E; Nicolin A; Olivani P
Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:291-. PubMed ID: 4115298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
